Otros idiomas Fractyl Health, Inc.

Acciones

GUTS

US35168W1036

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 13/05/2024			Varia. Cinco días.	Varia. 1 de enero.
6,1 ^USD	-1,45 %		-3,79 %	0,00 %

17:43	Fractyl Health afirma que los nuevos datos de Revita muestran una pérdida de peso sostenida y un control de la glucosa en la diabetes de tipo 2	MT
02/04	Fractyl Health nombra a Adrian Kimber director comercial; las acciones bajan	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Earnings Flash (GUTS) FRACTYL HEALTH Reports Q1 Revenue $33,000	22:02
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates	22:00
Fractyl Health Says New Revita Data Show Sustained Weight Loss, Glucose Control in Type 2 Diabetes	17:43
Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)	12:00
Fractyl Health to Present at BofA Securities 2024 Health Care Conference	08/05
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024	07/05
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting	30/04
Fractyl Health Names Adrian Kimber Chief Commercial Officer; Shares Down	02/04
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes	02/04
Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes	02/04
Fractyl Health, Inc. Announces Appointment of Adrian Kimber as Chief Commercial Officer	02/04
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures	01/04
Rising Rate Cut Hopes Buoy Exchange-Traded Funds, Equity Futures Pre-Bell Monday	01/04
Top Premarket Decliners	01/04
Fractyl Health Shares Drop After Wider 4Q Loss	01/04
Earnings Flash (GUTS) FRACTYL HEALTH Posts Q4 Revenue $7,000	01/04
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	01/04
Fractyl Health, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/04
Fractyl Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Fractyl Health Shares Rise 40% After FDA Approval of IDE for Revita	01/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Fractyl Health, Inc.

Acciones

GUTS

US35168W1036

Otros idiomas

Filtros